So many ligands, so few transcription factors: A new paradigm for signaling through the STAT transcription factors

Cytokine

Volumn 15, Issue 4, 2001, Pages 175-187

  Subramaniam, Prem S ^a   Torres, Barbara A ^a   Johnson, Howard M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPHYCOCYANIN; ALPHA INTERFERON; BRCA1 PROTEIN; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GROWTH FACTOR; GUANOSINE TRIPHOSPHATASE; HYBRID PROTEIN; INTERLEUKIN 10; KARYOPHERIN; LIGAND; MUTANT PROTEIN; RAN PROTEIN; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR;

CELL NUCLEUS; CELLULAR DISTRIBUTION; GENETIC TRANSCRIPTION; HUMAN; INTRACELLULAR TRANSPORT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0035928897     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.0905     Document Type: Review

References (133)

1. STAT proteins and transcriptional responses to extracellular signals
2. How cells respond to interferons
3. Regulation of STAT-dependent pathways by growth factors and cytokines
4. Nuclear signaling pathways for polypeptide ligands and their membrane receptors?
5. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation
6. Direct association of STAT3 with the IFNAR-1 chain of the human type 1 interferon receptor
7. Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells
8. The role of STAT4 in species-specific regulation of Th cell development by type I IFNs
9. Interleukin-1 beta activates a short STAT-3 isoform in clonal insulin-secreting cells
10. A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene
11. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes
12. The role of STAT5a and STAT5b in signaling by IL-2 family cytokines
13. Interleukin 3 activates not only JAK2 and STAT5, but also TYK2, STAT1, and STAT3
14. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5
15. Interleukin-3 signals through multiple isoforms of STAT5
16. Cloning of murine STAT6 and human STAT6, STAT proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis
17. Binding of IL-4 to the IL-13(Ralpha(l)/1L-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation
18. The mechanism of IL-5 signal transduction
19. JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
20. Signaling by cytokines interacting with the interleukin-2 receptor gamma chain
21. Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9
22. JAK-STAT signal transduction pathway through the eyes of cytokine class II receptor complexes
23. IL-10 induces the tyrosine phosphotylation of TYK2 and JAK1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes
24. IL-10 induces DNA binding activity of three STAT proteins (STAT1, STAT3, and STAT5) and their distinct combinatorial assembly in the promoters of selected genes
25. Association of transcription factor APRF and protein kinase JAK1 with the interleukin-6 signal transducer gp130
26. Signal transduction through homo- or heterodimers of gp130
27. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family
28. Interleukin 12 signaling in T helper type (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (STAT)3 and STAT4
29. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFNalpha
30. Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1
31. The role of shared receptor motifs and common STAT proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15
32. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells
33. IL-15 enhances the response of human gamma delta T cells to nonpeptide microbial antigens
34. Evidence for the involvement of JAK/STAT pathway in the signaling of interleukin-17
35. Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain
36. Cytokines: IL-21 joins the gamma(c)-dependent network?
37. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R
38. Oligodendroglial survival factors, PDGF-AA and CNTF, activate similar JAK/STAT signaling pathways
39. Activation of STAT5 by platelet derived growth factor (PDGF) is dependent on phosphorylation sites of PDGF beta-receptor juxtamembrane and kinase insert domains
40. STAT5 is a physiological substrate of the insulin receptor
41. Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation
42. In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of STAT3
43. Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of JAK2 and STAT proteins
44. Prolactin, growth hormone, erythropoietin, and granulocyte-macrophage colony stimulating factor induce MGF-STAT5 DNA binding activity
45. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone
46. Polypeptide signaling to the nucleus through tyrosine phosphorylation of JAK and STAT proteins
47. Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei
48. STAT3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6
49. An epidermal growth factor receptor/JAK2 tyrosine kinase domain chimera induces tyrosine phosphorylation of STAT5 and transduces a growth signal in hematopoietic cells
50. Erythropoietin induces the tyrosine phosphorylation nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells
51. Choice of STATs and other substrates specified by modular tyrosine-based motifa in cytokine receptors
52. Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells
53. FGF signaling inhibits chndrocyte proliferation and regulates bone development through the STAT-1 pathway
54. Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes
55. Characterization of insulin-like growth factor-1-induced activation of the JAK/STAT pathway in rat cardiomyocytes
56. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs
57. Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates P93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes
58. STAT1 associates with c-kit and is activated in response to stem cell factor
59. STAT protein recruitment and activation in c-Kit deletion mutants
60. Direct stimulation of JAK/STAT pathway by the angiotensin II ATI receptor
61. Activation of the STAT pathway by angiotensin II in T3CHO/AT1A cells. Cross-talk between angiotensin II and interleukin-6 nuclear signaling
62. Angiotensin II activates STAT5 through JAK2 kinase in cardiac myocytes
63. Defective STAT signaling by the leptin receptor in diabetic mice
64. The JAK/STAT pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells
65. Urokinase induces activation and formation of STAT4 and STAT1-STAT2 complexes in human vascular smooth muscle cells
66. Requirement of STAT3 but not STAT1 activation for epidermal growth factor receptor-mediated cell growth in vitro
67. Leukemia inhibitory factor as a mediator of JAK/STAT activation in murine osteoblasts
68. JAK/STAT signaling induced by the v-abl oncogene
69. Constitutive activation of STAT3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells
70. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression
71. Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity
72. Nucleocytoplasmic transport
73. Nuclear targeting signal recognition: A key control point in nuclear transport?
74. Interferon-γ-dependent nuclear import of STAT1 is mediated by the GTPase activity of Ran/TC4
75. Extracellular signal-dependent nuclear import of STAT1 is mediated by nuclear pore-targeting complex formation with NpI-1, but not Rch 1
76. A nuclear localization signal of human aryl hydrocarbon translocation/hypoxia - Inducible factor 1b 1 a novel bipartite type recognized by the two components of the nuclear pore-targeting complex
77. Transport of γ-interferon into the cell nucleus may not be mediated by nuclear membrane receptors
78. Nuclear accumulation of interferon γ
79. Nuclear targeting sequences: A consensus?
80. Mutational analysis of the C-terminus of human interferon-γ
81. The carboxy-terminal region of human interferon-γ is important for biological activity: Mutagenic c and NMR analysis
82. Role of the carboxy-terminal sequence on the biological activity of human interferon (IFN-γ)
83. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-γ encapsulated in liposomes
84. Intracellular human interferon-γ triggers an antiviral state in transformed murine L cells
85. Direct evidence for an intracellular role for IFN-γ. Microinjection of human IFN-γ induces Ia expression on murine macrophages
86. Expression of intracellular interferon constitutively activates ISGF3 and confers resistance to EMC viral infections
87. The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence
88. The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site
89. Differential properties of two putative nuclear localization sequences found in the carboxyl terminus of human IFN-γ
90. The C-terminus of IFN gamma is sufficient for intracellular function
91. Unrestricted agonist activity on murine and human cells of a lipopeptide derived from IFN-gamma
92. Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma
93. Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules
94. Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin
95. Epidermal growth factor-mediated caveolin: Recruitment to early endosomes and MAPK activation
96. Chimeric interferon-gamma receptors demonstrate that an accessory factor required for activity interacts with the extracellular domain
97. The extracellular domain of the human interferon gamma receptor interacts with a species-specific signal transducer
98. Functional characterization of a hybrid human-mouse interferon gamma receptor: Evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer
99. The human gamma interferon receptor accessory factor encoded by chromosome 21 transduces the signal for the induction of 2′,5′-oligoadenylate-synthetase, resistance to virus cytopathic effect, and major histocompatibility complex class I antigens
100. Identification of an interferon-g receptor a chain sequence required
101. Identification of IFN-gamma receptor binding sites for JAK2 and enchancement of binding by IFN-gamma and its C-terminal peptide IFN-gamma(95-133)
102. Interaction between the components of the γ-interferon complex
103. The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence
104. The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site
105. Interferon regulator factor localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors
106. How STAT1 mediates constitutive gene expression: A complex of unphosphorylated STAT1 and IRF1 supports transcription of the LMP2 gene
107. Cross-talk between interferon-γ and - α/β signaling components in caveolar membrane domains
108. Chimeric erythropoietin-interferon γ receptors reveal differences in functional architecture of intracellular domains for signal transduction
109. Nuclear export signal located within the DNA-binding domain of the STAT1 transcription factor
110. Regulation of STAT1 nuclear export by Jak1
111. Constitutive nuclear localization of Janus kinases 1 and 2
112. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase
113. A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of STAT5b
114. Arginine/lysine-rich structural element is involved in IFN-induced nuclear import of STATs
115. STATs in oncogenesis
116. JAK-STAT signaling activated by Ab1 oncogenes
117. The CML-specific P210 bcr/ab1 protein, unlike v-abl, does not transform N1H/3T3 fibroblasts
118. Direct interaction of JAK1 and v-ab1 is required for v-ab1-induced activation of STATs and proliferation
119. Nuclear localization of v-ab1 leads to complex formation with cyclic AMP response element (CRE)-binding protein and transactivation through CRE motifs
120. Enhanced DNA-binding activity of a STAT3-related protein in cells transformed by the Src oncoprotein
121. Activation and association of STAT3 with Src in v-Src-transformed cell lines
122. Constitutive activation of JAK1 in Src-transformed cells
123. Constitutive activation of JAK2 and TYK2 in a v-Src-transformed human gall bladder adenocarcinoma cell line
124. Functional interaction between c-Src and its mitotic target, Sam 68
125. Selected glimpses into the activation and function of Src kinase
126. The quaking 1-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm
127. STAR, a gene family involved in signal transduction and activation of RNA
128. Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation
129. Signaling network of the Btk family kinases
130. STAT1 is not essential for inhibition of B lymphopoiesis by type I IFNs
131. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox